Asmodium falciparum identification and tracking. Malar J 2008, 7:223. Trager W, Jensen JB: Human malaria parasites in continuous culture. Science 1976, 193:67375. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrian F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA: In silico activity profiling reveals the mechanism of action of antimalarials found in a high-throughput screen. Proc Natl Acad Sci U S A 2008, 105:9059064. Zhang JH, Chung TD, Oldenburg KR: A basic statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999, 4:673.Van Tyne et al. Malaria Journal 2013, 12:441 http://www.malariajournal/content/12/1/Page ten of25. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Bjorkman A: Recovery of chloroquine sensitivity and low prevalence from the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 2003, 68:41315. 26. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE: Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A 2009, 106:188838889. 27. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Cost RN, Ringwald P: A systematic critique and meta-analysis of evidence for correlation involving molecular markers of parasite resistance and therapy outcome in falciparum malaria. Malar J 2009, 8:89. 28. Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM: Association involving mutations in Plasmodium falciparum chloroquine resistance transporter and P.S1p receptor agonist 1 falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P.Emodepside falciparum malaria-infected kids in Nigeria. Am J Trop Med Hyg 2006, 75:15561. 29. Pascual A, Parola P, Benoit-Vical F, Simon F, Malvy D, Picot S, Delaunay P, Basset D, Maubon D, Faugere B, Menard G, Bourgeois N, Oeuvray C, Didillon E, Rogier C, Pradines B: Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with standard ACT drugs against isolates of Plasmodium falciparum. Malar J 2012, 11:45. 30. Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G: Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an location of Uganda exactly where malaria is very endemic. Antimicrob Agents Chemother 2006, 50:1893895. 31. Gadalla NB, Adam I, Elzaki SE, Bashir S, Mukhtar I, Oguike M, Gadalla A, Mansour F, Warhurst D, El-Sayed BB, Sutherland CJ: Improved pfmdr1 copy quantity and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria individuals treated with artemether-lumefantrine.PMID:24013184 Antimicrob Agents Chemother 2011, 55:5408411. 32. Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, Diatta B, Fall KB, Mbaye PS, Fall F, Dieme Y, Rogier C, Bercion R, Briolant S, Wade B, Pradines B: Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J 2012, 11:197. 33. Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, Dieme Y, Briolant S, Bercion R, Wade B, Tall A, Pradines B: Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J two.
Related Posts
To date, the definite and precise role of TNIP1 in psoriatic epidermal cells remains unclear
rker genes were overexpressed in U3-C and U3-DT. U3-A has the potential to differentiate into several types of cell, including adipocytes and osteoblasts. Gene expression of markers characteristic of these cell types was down-regulated in U3-DT cells. Expression of adhesion-related genes was strongly suppressed in U3-C and U3-DT, with the exception of COL4A5, a member […]
As recently been developed and consists of cell cycle markers, likeAs recently been developed and
As recently been developed and consists of cell cycle markers, likeAs recently been developed and consists of cell cycle markers, like urinary tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin like growth factor-binding protein 7 (IGFBP-7). Probably the most promising application of these biomarkers in oncology is their potential for early detection of nephrotoxicity by antineoplastic […]
Degeneration in PD. Neurotherapeutics against PD shall then be targeted against the misregulated accomplices from
Degeneration in PD. Neurotherapeutics against PD shall then be targeted against the misregulated accomplices from the p38 and PI3KAKT cascades. In this assessment, we’ve outlined a lot of such established mechanisms involving the p38 MAPK and PI3KAKT pathways which can give therapeutic windows for the rectification of aberrant DA neuronal dynamics in PD brains.Key words: […]